Search research articles
Contact Us
Filters
Showing results (361-370 of 499) with videos related to
Page
of 50
Sort By:
Journal for Immunotherapy of Cancer
|
December 11, 2021
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival
Manish A Shah, David Cunningham, Jean-Philippe Metges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 2019
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With <i>BRAF</i> V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
Eric Van Cutsem, Sanne Huijberts, Axel Grothey, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 22, 2026
Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients
Hannes Leupe, Sophie-Anne De Buyst, Jeroen Dekervel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 29, 2026
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials
Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial
Alfredo Carrato, Anna Swieboda-Sadlej, Marzanna Staszewska-Skurczynska, et al.
Endoscopy
|
January 16, 2019
Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trial
Philip Roelandt, Ingrid Demedts, Hilde Willekens, et al.
The Lancet. Oncology
|
July 18, 2015
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
Josep Tabernero, Heinz-Josef Lenz, Salvatore Siena, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 15, 2009
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)
Vincenzo Valentini, Cynthia Aristei, Bengt Glimelius, et al.
The Lancet. Oncology
|
October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Page
of 50
Search research articles
Search
Showing results (361-370 of 499) with videos related to
Sort By:
Page
of 50
Journal for Immunotherapy of Cancer
|
December 11, 2021
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival
Manish A Shah, David Cunningham, Jean-Philippe Metges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 2019
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With <i>BRAF</i> V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
Eric Van Cutsem, Sanne Huijberts, Axel Grothey, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 22, 2026
Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients
Hannes Leupe, Sophie-Anne De Buyst, Jeroen Dekervel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 29, 2026
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials
Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial
Alfredo Carrato, Anna Swieboda-Sadlej, Marzanna Staszewska-Skurczynska, et al.
Endoscopy
|
January 16, 2019
Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trial
Philip Roelandt, Ingrid Demedts, Hilde Willekens, et al.
The Lancet. Oncology
|
July 18, 2015
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
Josep Tabernero, Heinz-Josef Lenz, Salvatore Siena, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 15, 2009
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)
Vincenzo Valentini, Cynthia Aristei, Bengt Glimelius, et al.
The Lancet. Oncology
|
October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Page
of 50